Hexagon Capital Partners LLC Verona Pharma PLC Transaction History
Hexagon Capital Partners LLC
- $508 Million
- Q3 2024
A detailed history of Hexagon Capital Partners LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 3 shares of VRNA stock, worth $119. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$119% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
151Shares Held
65.8MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$304 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$223 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$159 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$142 Million7.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.31MShares$132 Million2.82% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.43B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...